Likewise, in comparison with the control group, mRNA expression levels of REG3A was significantly (p < 0.01) higher in PBMCs from PM/DM patients, while miR-146a expression was markedly downregulated (p < 0.01). Here, REG3A is linked to dermatomyositis.